Search

everythinglearnresearchcommunity

for

Search:↓

CD28 is a promising target for treating alopecia areata with belatacept.

The first Japanese case of a genetic hair disorder caused by specific mutations in the LIPH gene was identified.

Cubosomal gels enhance skin absorption of cetirizine better than niosomal gels.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

A rare genetic disorder causes sparse hair and vision loss due to a CDH3 gene mutation.

Blocking CXXC5 speeds up diabetic wound healing by improving blood vessel growth and skin repair.

New probes were created to effectively measure specific enzymes involved in fat metabolism, which could help develop new drugs.

HX109 herbal extract helps hair grow by boosting cell growth and reducing cell death.

A group has developed therapies that show promise for treating cancer and various other conditions.

KCNQ potassium channels help control the sensitivity of touch receptors in the skin.

Rituximab may be an effective treatment for Cronkhite-Canada syndrome with kidney disease.

Mice with extra PKCδ resist chemical-induced skin cancer but not UV-induced.

The tumor suppressor BRCA2 helps in cell division by bringing key proteins to the area where cells split.

Genetic testing is crucial for diagnosing and managing non-Herlitz junctional epidermolysis bullosa.

HGF combined with ADA is highly accurate for diagnosing tuberculous pleural effusion, especially in younger females.

A 78-year-old man with Cronkhite-Canada syndrome improved significantly after treatment and remains symptom-free.

Hairless protein can both repress and activate vitamin D receptor functions, affecting gene regulation.

A rare type of skin cancer with mucosal involvement was partially treated but eventually relapsed.

K10 may not prevent tumors as previously thought and might increase benign tumor risk.

Hedgehog pathway inhibitors could be effective in treating melanoma.

Bioengineered skin models aging well, useful for studying aging and testing treatments.

The May issue discussed publishing agreements and four studies on cholesterol in hair, cancer cell changes, hormones in the uterus, and skin protein effects.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Diphencyprone initially increases mouse hair growth, then slows it, possibly due to changes in specific protein levels.

Mouse skin has special cells in the epidermis that decrease with age and are linked to keratinocyte stem cells.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

Notch signaling is crucial for specifying niche cells in Drosophila testis.

Ivacaftor can protect against noise-induced hearing loss by reducing oxidative stress.